
Eric Olson
Examiner (ID: 15792, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1623, 1693 |
| Total Applications | 1700 |
| Issued Applications | 960 |
| Pending Applications | 118 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10621682
[patent_doc_number] => 09340619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'DAC HYP compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 14/671653
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 31
[patent_no_of_words] => 32735
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671653
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/671653 | DAC HYP compositions and methods | Mar 26, 2015 | Issued |
Array
(
[id] => 11922965
[patent_doc_number] => 09790536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Methods for assaying alpha-L-iduronidase enzymatic activity'
[patent_app_type] => utility
[patent_app_number] => 14/659483
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11694
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14659483
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/659483 | Methods for assaying alpha-L-iduronidase enzymatic activity | Mar 15, 2015 | Issued |
Array
(
[id] => 10676582
[patent_doc_number] => 20160022727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/631760
[patent_app_country] => US
[patent_app_date] => 2015-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 21009
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14631760
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/631760 | IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS | Feb 24, 2015 | Abandoned |
Array
(
[id] => 11492609
[patent_doc_number] => 20170066794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM'
[patent_app_type] => utility
[patent_app_number] => 15/119880
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8264
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15119880
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/119880 | Synthetic oligomers of | Feb 23, 2015 | Issued |
Array
(
[id] => 12546363
[patent_doc_number] => 10011662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Downstream process for purifying polysaccharides
[patent_app_type] => utility
[patent_app_number] => 15/119847
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3123
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15119847
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/119847 | Downstream process for purifying polysaccharides | Feb 23, 2015 | Issued |
Array
(
[id] => 11335517
[patent_doc_number] => 20160361272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'EDIBLE COMPOSITION INCLUDING SAFRANAL, CROCIN, PICROCROCIN AND A VITAMIN B COMPLEX FOR TREATING THE INITIAL PHASE OF DEPRESSION'
[patent_app_type] => utility
[patent_app_number] => 15/120838
[patent_app_country] => US
[patent_app_date] => 2015-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3564
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120838
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/120838 | EDIBLE COMPOSITION INCLUDING SAFRANAL, CROCIN, PICROCROCIN AND A VITAMIN B COMPLEX FOR TREATING THE INITIAL PHASE OF DEPRESSION | Feb 22, 2015 | Abandoned |
Array
(
[id] => 12945601
[patent_doc_number] => 09834573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => Crystalline form of benzylbenzene SGLT2 inhibitor
[patent_app_type] => utility
[patent_app_number] => 14/627693
[patent_app_country] => US
[patent_app_date] => 2015-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 13643
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14627693
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/627693 | Crystalline form of benzylbenzene SGLT2 inhibitor | Feb 19, 2015 | Issued |
Array
(
[id] => 11604060
[patent_doc_number] => 20170121361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'Hydrolysis Resistant Sialic Acid Derivatives and Methods for Their Use'
[patent_app_type] => utility
[patent_app_number] => 15/119622
[patent_app_country] => US
[patent_app_date] => 2015-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19186
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15119622
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/119622 | Hydrolysis resistant sialic acid derivatives and methods for their use | Feb 17, 2015 | Issued |
Array
(
[id] => 10265903
[patent_doc_number] => 20150150900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'High Molecular Weight Heparosan Polymers and Methods of Production and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/624354
[patent_app_country] => US
[patent_app_date] => 2015-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15924
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14624354
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/624354 | High Molecular Weight Heparosan Polymers and Methods of Production and Use Thereof | Feb 16, 2015 | Abandoned |
Array
(
[id] => 10339470
[patent_doc_number] => 20150224475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'METHODOLOGY FOR THE FORMATION OF AN EXTRACTIVE AGENT OF POLYMERIZED CARBON NANOTUBES ENCAPSULATING PHENOL NANOPARTICLES USED FOR DNA EXTRACTION AND PURIFICATION, AND PRODUCT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/615398
[patent_app_country] => US
[patent_app_date] => 2015-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 3533
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14615398
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/615398 | Methodology for the formation of an extractive agent of polymerized carbon nanotubes encapsulating phenol nanoparticles used for DNA extraction and purification, and product thereof | Feb 4, 2015 | Issued |
Array
(
[id] => 10318580
[patent_doc_number] => 20150203583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'DAC HYP COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/601909
[patent_app_country] => US
[patent_app_date] => 2015-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 32836
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14601909
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/601909 | DAC HYP compositions and methods | Jan 20, 2015 | Issued |
Array
(
[id] => 11335534
[patent_doc_number] => 20160361289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 15/113127
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18085
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113127
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/113127 | Treatment of metabolic disorders in canine animals | Jan 19, 2015 | Issued |
Array
(
[id] => 10311579
[patent_doc_number] => 20150196581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/600253
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15268
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14600253
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/600253 | Compositions for external application, containing adenosylcobalamin for improvement of skin diseases | Jan 19, 2015 | Issued |
Array
(
[id] => 11684067
[patent_doc_number] => 09682099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Compositions and methods for treating joints'
[patent_app_type] => utility
[patent_app_number] => 14/600770
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 15507
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14600770
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/600770 | Compositions and methods for treating joints | Jan 19, 2015 | Issued |
Array
(
[id] => 11684933
[patent_doc_number] => 09682969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Phthalazinone compounds and methods for the treatment of cystic fibrosis'
[patent_app_type] => utility
[patent_app_number] => 14/599998
[patent_app_country] => US
[patent_app_date] => 2015-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10855
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14599998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/599998 | Phthalazinone compounds and methods for the treatment of cystic fibrosis | Jan 18, 2015 | Issued |
Array
(
[id] => 10255179
[patent_doc_number] => 20150140176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'Carbohydrate Gel'
[patent_app_type] => utility
[patent_app_number] => 14/599197
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5827
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14599197
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/599197 | Carbohydrate Gel | Jan 15, 2015 | Abandoned |
Array
(
[id] => 13263267
[patent_doc_number] => 10143703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-04
[patent_title] => Treating ocular neovascularization
[patent_app_type] => utility
[patent_app_number] => 15/108751
[patent_app_country] => US
[patent_app_date] => 2015-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 86
[patent_no_of_words] => 15112
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108751 | Treating ocular neovascularization | Jan 1, 2015 | Issued |
Array
(
[id] => 10311575
[patent_doc_number] => 20150196577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'Compounds, Compositions and Methods for Protecting Brain Health in Neurodegenerative Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/584581
[patent_app_country] => US
[patent_app_date] => 2014-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 28409
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14584581
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/584581 | Compounds, compositions and methods for protecting brain health in neurodegenerative disorders | Dec 28, 2014 | Issued |
Array
(
[id] => 10457957
[patent_doc_number] => 20150342973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'ANTIBIOTIC COMPOSITIONS AND RELATED SCREENING METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/578453
[patent_app_country] => US
[patent_app_date] => 2014-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9186
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14578453
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/578453 | ANTIBIOTIC COMPOSITIONS AND RELATED SCREENING METHODS | Dec 20, 2014 | Abandoned |
Array
(
[id] => 10220474
[patent_doc_number] => 20150105467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN'
[patent_app_type] => utility
[patent_app_number] => 14/576404
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4354
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14576404
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/576404 | FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN | Dec 18, 2014 | Abandoned |